DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Electrocardiograph Market 2021-2031 by Product Type, Lead Type, Function, Technology, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.
The Asia Pacific electrocardiograph (ECG) market will grow by 8.2% annually with a total addressable market cap of $32,834.0 million over 2022-2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare expenditure.
This report is based on a comprehensive research of the entire Asia Pacific electrocardiograph (ECG) market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific electrocardiograph (ECG) market in every aspect of the classification from perspectives of Product Type, Lead Type, Function, Technology, End User, and Country.
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Conventional Devices
Resting ECG Devices
Stress ECG Devices
Emerging Devices
Implantable Loop Recorders
Mobile Cardiac Telemetry
Holter Monitors
Cardiac Event Monitors
Smart ECG Monitors
Software & Services
Based on Lead Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Single-Lead Type ECG Devices
3-Lead Type ECG Devices
5-Lead Type ECG Devices
6-Lead Type ECG Devices
12-Lead Type ECG Devices
Other Lead Types
By Function, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Diagnostic ECG Systems
Monitoring ECG Systems
By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Portable ECG Systems
Wireless ECG Systems
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)
Home-based Users
Cardiac Centers
Other End Users
Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($mn) are available for 2021-2031. The breakdown of national markets by Product Type, Lead Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
ACS Diagnostics
Biotricity, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
CardioComm Solutions, Inc.
Cardioline SpA
Edan Instruments, Inc.
Fukuda Denshi Co., Ltd.
General Electric Company
Hill-Rom Holdings, Inc.
iRhythm Technologies, Inc.
Koninklijke Philips N.V.
Medtronic plc
Mindray Medical International Limited
Nihon Kohden Corporation
OSI Systems, Inc.
Schiller AG
Suzuken Co., Ltd.
Zoll Medical Corporation (Asahi Kasei Corporation)
For more information about this report visit https://www.researchandmarkets.com/r/ougl8u
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
